EP1509204A4 - Particules agglomerees comprenant un principe actif cotraite avec de la cellulose microcristalline silicifiee - Google Patents

Particules agglomerees comprenant un principe actif cotraite avec de la cellulose microcristalline silicifiee

Info

Publication number
EP1509204A4
EP1509204A4 EP01274926A EP01274926A EP1509204A4 EP 1509204 A4 EP1509204 A4 EP 1509204A4 EP 01274926 A EP01274926 A EP 01274926A EP 01274926 A EP01274926 A EP 01274926A EP 1509204 A4 EP1509204 A4 EP 1509204A4
Authority
EP
European Patent Office
Prior art keywords
coprocessed
active agent
microcrystalline cellulose
agglomerated particles
particles including
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01274926A
Other languages
German (de)
English (en)
Other versions
EP1509204A1 (fr
Inventor
Robert Sherwood
Joseph A Zeleznik
David Schaible
Wilhelm Berkulin
Karl-Hans Theissing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
J Rettenmaier and Soehne GmbH and Co KG
Original Assignee
J Rettenmaier and Soehne GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Rettenmaier and Soehne GmbH and Co KG filed Critical J Rettenmaier and Soehne GmbH and Co KG
Publication of EP1509204A1 publication Critical patent/EP1509204A1/fr
Publication of EP1509204A4 publication Critical patent/EP1509204A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
EP01274926A 2001-11-29 2001-11-29 Particules agglomerees comprenant un principe actif cotraite avec de la cellulose microcristalline silicifiee Withdrawn EP1509204A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/044928 WO2003047551A1 (fr) 2001-11-29 2001-11-29 Particules agglomerees comprenant un principe actif cotraite avec de la cellulose microcristalline silicifiee

Publications (2)

Publication Number Publication Date
EP1509204A1 EP1509204A1 (fr) 2005-03-02
EP1509204A4 true EP1509204A4 (fr) 2005-07-13

Family

ID=21743033

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01274926A Withdrawn EP1509204A4 (fr) 2001-11-29 2001-11-29 Particules agglomerees comprenant un principe actif cotraite avec de la cellulose microcristalline silicifiee

Country Status (3)

Country Link
EP (1) EP1509204A4 (fr)
AU (1) AU2002219964A1 (fr)
WO (1) WO2003047551A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2008035354A1 (fr) * 2006-09-21 2008-03-27 Unijules Life Sciences Ltd. Pastilles d'extraits d'herbes et son procédé de préparation
WO2008059522A2 (fr) * 2006-09-28 2008-05-22 Unijules Life Sciences Ltd Formes posologiques d'administration contrôlée de médicament gastro-intestinale à base d'herbe comprenant des pastilles et leur procédé de préparation
MX2009008935A (es) 2007-02-23 2009-11-02 Gilead Sciences Inc Moduladores de las propiedades farmacocineticas de productos terapeuticos.
CH698627B1 (de) 2007-08-16 2009-09-15 Alpinia Laudanum Inst Of Phytopharmaceutical Herstellung und Verwendung von Extrakten oder Extraktivstoffen aus Piper cubeba L. als wirksame Bestandteile in einem Medikament zur Behandlung von Krebserkrankungen.
DE102007045686A1 (de) * 2007-09-24 2009-04-02 J. Rettenmaier & Söhne Gmbh + Co. Kg Verfahren zur Herstellung frei fließender, pulverförmiger Extrakte mit Hilfe der Wirbelschicht Trocknung
EA201591353A1 (ru) 2008-05-02 2016-01-29 Джилид Сайэнс, Инк. Применение частиц твердого носителя для улучшения технологических характеристик фармацевтического агента
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
CN104472880B (zh) * 2014-12-12 2017-09-01 四川乾坤生物科技有限公司 一种兽药组合物及其制备方法和用途
WO2016128386A1 (fr) 2015-02-09 2016-08-18 Vereeken Jose Formulation multiparticulaire comprenant des extraits de plante
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212948A1 (fr) 2019-04-17 2020-10-22 Compass Pathfinder Limited Procédés pour traiter les troubles neurocognitifs, la douleur chronique, et pour réduire l'inflammation
WO2023285952A1 (fr) 2021-07-10 2023-01-19 Auxilius Pharma Spolka Z Ograniczona Odpowiedzialnoscia Formulations de composés de nicorandil à libération modifiée

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
WO2001074448A1 (fr) * 2000-03-30 2001-10-11 Mova Pharmaceutical Corporation Preparations stables d'hormones thyroidiennes et leur procede de fabrication
EP1297825A1 (fr) * 2001-09-28 2003-04-02 McNEIL-PPC, INC. Forme orale solide de siméthicone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6103219A (en) * 1995-01-09 2000-08-15 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
WO2001074448A1 (fr) * 2000-03-30 2001-10-11 Mova Pharmaceutical Corporation Preparations stables d'hormones thyroidiennes et leur procede de fabrication
EP1297825A1 (fr) * 2001-09-28 2003-04-02 McNEIL-PPC, INC. Forme orale solide de siméthicone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03047551A1 *

Also Published As

Publication number Publication date
AU2002219964A1 (en) 2003-06-17
WO2003047551A1 (fr) 2003-06-12
EP1509204A1 (fr) 2005-03-02

Similar Documents

Publication Publication Date Title
EP1509204A4 (fr) Particules agglomerees comprenant un principe actif cotraite avec de la cellulose microcristalline silicifiee
AU2002243370A1 (en) Body supported activity and condition monitor
AU2001261150A1 (en) Methods and systems for compliance program assessment
EP1519737A4 (fr) Nanoparticules de fibrine et leurs utilisations
AU2001294887A1 (en) Retention socket geometry variations
AU2001292338A1 (en) Functional alloy particles
GB0216197D0 (en) Serrs active particles
GB2378826B (en) Connector and connector housing
AU2002245199A1 (en) Sulfur-absorbent bed and fuel processing assembly incorporating the same
EP1439017B8 (fr) Particules métalliques sphériques pour monodispersion.
AU2002236710A1 (en) Processing particulate ni-ti shape memory alloys
AU2001264671A1 (en) Latency monitor
AU148184S (en) Sprinkler housing
AU2001283862A1 (en) Bvdv virus-like particles
AU2002349882A1 (en) Q4n2neg2 enhances cftr activity
AU2002233229A1 (en) Method for producing dimensionally stable, spherical carbohydrate particles and the use thereof
GB0218833D0 (en) Connector and connector housing
AU2001265281A1 (en) Electrochemical reduction of nitrate in the presence of an amide
EP1364031A4 (fr) Particules de type vih et utilisation de celles-ci
AU2002320942A1 (en) Flame-proofing agent and means for the production thereof
EP1394905A4 (fr) Connecteur pour composant electroacoustique et structure de connexion de ce connecteur
AU2003230172A1 (en) Spherical and nearly spherical view imaging assembly
AU2003205791A1 (en) Active substance diffuser
AU2002250977A1 (en) Combination of active ingredients consisting of the racemate of tramadol and of (+)-o-desmethyltramadol
AU2002234219A1 (en) Granular composition comprising an active compound and a cellulose ether and the use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040827

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: J. RETTENMAIER & SOEHNE GMBH + CO. KG

A4 Supplementary search report drawn up and despatched

Effective date: 20050601

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 35/78 B

Ipc: 7A 61K 9/20 B

Ipc: 7A 61K 9/16 B

Ipc: 7A 61K 9/14 A

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1073610

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101015

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1073610

Country of ref document: HK